Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerular Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT06752876
What this trial is testing

CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP)

Who this might be right for
Systemic Lupus ErythematosusLupusLupus Erythematosus+1 more
Caribou Biosciences, Inc.
Testing effectiveness (Phase 2)Study completedNCT01613118
What this trial is testing

Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental Glomerulosclerosis
Travere Therapeutics, Inc. 109
Not applicableStudy completedNCT05200871
What this trial is testing

Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy)

Who this might be right for
Focal Segmental GlomerulosclerosisImmunoglobulin A Nephropathy
Travere Therapeutics, Inc. 487
Not applicableLooking for participantsNCT07516964
What this trial is testing

SLIT ABS: Study on Patients With Autoimmune Podocytopathy

Who this might be right for
Nephrotic Syndrome With Edema (Diagnosis)Minimal Change Nephrotic SyndromeFocal Segmental Glomerulosclerosis (FSGS)+1 more
Meyer Children's Hospital IRCCS 50
Not applicableStudy completedNCT06460987
What this trial is testing

Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy

Who this might be right for
FinerenoneIgA NephropathyProteinuria+1 more
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 245
Post-approval studies (Phase 4)Ended earlyNCT03920059
What this trial is testing

Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Chulalongkorn University 2
Early research (Phase 1)Study completedNCT04128579
What this trial is testing

Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis

Who this might be right for
Lupus ErythematosusLupus Nephritis
Biocon Limited 52
Testing effectiveness (Phase 2)Study completedNCT04340362
What this trial is testing

Phase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis

Who this might be right for
Glomerulosclerosis, Focal Segmental
Vertex Pharmaceuticals Incorporated 16
Not applicableLooking for participantsNCT05588063
What this trial is testing

TaVNS for FRNS in Children

Who this might be right for
Nephrotic Syndrome in ChildrenMinimal Change DiseaseFocal Segmental Glomerulosclerosis
Northwell Health 30
Testing effectiveness (Phase 2)Ended earlyNCT04154787
What this trial is testing

Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Novartis Pharmaceuticals 37
Not applicableStudy completedNCT05182775
What this trial is testing

A Clinical Research on the Use of Fecal Bacteria Transplantation for Treatment of IgA Nephropathy

Who this might be right for
IgA Nephropathy
Shanxi Provincial People's Hospital 15
Not applicableLooking for participantsNCT07056595
What this trial is testing

Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial

Who this might be right for
IgA Nephropathy (IgAN)
Botkin Hospital 30
Large-scale testing (Phase 3)Study completedNCT02256150
What this trial is testing

Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Asahi Kasei Therapeutics Corporation 250
Testing effectiveness (Phase 2)UnknownNCT00659217
What this trial is testing

Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis

Who this might be right for
Lupus Nephritis
Organ Transplant Institute, China 20
Early research (Phase 1)WithdrawnNCT00816504
What this trial is testing

Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5

Who this might be right for
Focal Segmental Glomerulosclerosis
Northwell Health
Post-approval studies (Phase 4)UnknownNCT03214731
What this trial is testing

Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Sun Yat-sen University 90
Not applicableNot Yet RecruitingNCT07721857
What this trial is testing

Neutrophil Extracellular Traps and Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Assiut University 100
Large-scale testing (Phase 3)UnknownNCT01646736
What this trial is testing

Efficacy and Safety of Tripterygium Wilfordii in Patients With Lupus Nephritis

Who this might be right for
Nephritis, Lupus
Peking Union Medical College Hospital 130
Large-scale testing (Phase 3)Ended earlyNCT00368264
What this trial is testing

TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
Medical University of Vienna 1
Not applicableStudy completedNCT00801463
What this trial is testing

Prednisone Plus Tripterygium Wilfordii Treatment of Adult Patients With Idiopathic Focal Segmental Glomerulosclerosis

Who this might be right for
ProteinuriaFocal Segmental Glomerulosclerosis
Nanjing University School of Medicine 67
Next Page